Mavacamten for hypertrophic obstructive cardiomyopathy. 2021

Eduard Quintana, and Pietro Bajona, and Patrick O Myers
Department of Cardiovascular Surgery, Hospital ClĂ­nic de Barcelona, University of Barcelona, Barcelona, Spain.

UI MeSH Term Description Entries
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001596 Benzylamines Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group. Phenylmethylamine,alpha-Aminotoluene,alpha Aminotoluene
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.

Related Publications

Eduard Quintana, and Pietro Bajona, and Patrick O Myers
June 2022, The Medical letter on drugs and therapeutics,
Eduard Quintana, and Pietro Bajona, and Patrick O Myers
October 2023, JAMA cardiology,
Eduard Quintana, and Pietro Bajona, and Patrick O Myers
January 2021, Lancet (London, England),
Eduard Quintana, and Pietro Bajona, and Patrick O Myers
January 2023, Cardiovascular & hematological agents in medicinal chemistry,
Eduard Quintana, and Pietro Bajona, and Patrick O Myers
June 2019, Annals of internal medicine,
Eduard Quintana, and Pietro Bajona, and Patrick O Myers
June 2021, Current cardiology reports,
Eduard Quintana, and Pietro Bajona, and Patrick O Myers
October 2023, Journal of clinical medicine,
Eduard Quintana, and Pietro Bajona, and Patrick O Myers
February 2024, Mayo Clinic proceedings,
Eduard Quintana, and Pietro Bajona, and Patrick O Myers
May 2023, Trends in pharmacological sciences,
Eduard Quintana, and Pietro Bajona, and Patrick O Myers
January 2023, Drug design, development and therapy,
Copied contents to your clipboard!